Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-29 Sale | 2023-03-31 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 29,048 | $30.45 | $884,512 | 6,997,302 (Direct) | View |
| 2023-03-27 Sale | 2023-03-29 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 160,964 | $30.42 | $4,896,561 | 7,026,350 (Direct) | View |
| 2023-03-21 Sale | 2023-03-23 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 63,448 | $31.91 | $2,024,494 | 7,187,314 (Direct) | View |
| 2023-03-16 Sale | 2023-03-17 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 9,122 | $32.55 | $296,921 | 7,250,762 (Direct) | View |
| 2023-03-14 Sale | 2023-03-16 4:11 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 220,714 | $33.68 | $7,433,459 | 7,259,884 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 09:10 am | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 50,000 | $33.75 | $1,687,500 | 7,480,598 (Direct) | View |
| 2023-02-22 Sale | 2023-02-28 4:06 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 50,000 | $34.73 | $1,736,352 | 7,530,598 (Direct) | View |
| 2023-02-22 Sale | 2023-02-24 4:13 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 100,000 | $35.78 | $3,578,103 | 7,580,598 (Direct) | View |
| 2023-02-03 Sale | 2023-02-07 4:11 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 65,000 | $6.9842 | $453,970 | 5,447,993 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 4:32 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 90,000 | $7.0833 | $637,500 | 5,512,993 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:07 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 60,000 | $6.995 | $419,700 | 5,602,993 (Direct) | View |
| 2023-01-25 Sale | 2023-01-27 4:17 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 50,000 | $6.85 | $342,500 | 5,662,993 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 6:17 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 160,000 | $6.895 | $1,103,200 | 5,712,993 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:12 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 6,114 | $6.79 | $41,514 | 5,872,993 (Direct) | View |
| 2023-01-12 Sale | 2023-01-17 4:28 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 6,971 | $6.8774 | $47,943 | 5,879,107 (Direct) | View |
| 2023-01-05 Sale | 2023-01-09 4:08 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 15,162 | $6.9542 | $105,439 | 5,886,078 (Direct) | View |
| 2022-12-29 Sale | 2023-01-05 4:10 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 55,500 | $7.1378 | $396,150 | 5,901,240 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 4:05 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 32,312 | $8.7836 | $283,815 | 6,076,740 (Direct) | View |
| 2022-08-11 Purchase | 2022-08-15 6:48 pm | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd 10% Owner | 3,061,224 | $3.92 | $11,999,998 | 16,919,155 (Indirect Direct) | View |
| 2022-01-11 Purchase(A) | 2022-03-17 5:14 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 263,158 | $19 | $5,000,002 | 10,678,808 (Indirect) | View |
| 2022-02-02 Purchase(A) | 2022-03-17 5:11 pm | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 1,000,000 | $0 | $0 | 13,857,931 (Direct) | View |
| 2022-02-02 Purchase | 2022-02-04 5:15 pm | GreenLight Biosciences Holdings PBC | ENVI | Morningside Venture Investments Ltd 10% Owner | 1,000,000 | $0 | $0 | 13,858,188 (Direct) | View |
| 2022-01-11 Purchase | 2022-01-25 4:46 pm | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 263,158 | $19 | $5,000,002 | 10,678,808 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-18 4:16 pm | Apellis Pharmaceuticals Inc. | APLS | Morningside Venture Investments Ltd 10% Owner | 250,000 | $40 | $10,000,000 | 12,806,342 (Direct) | View |
| 2020-02-04 Purchase | 2020-02-06 4:11 pm | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 3,800,000 | $2.6 | $9,880,000 | 6,109,052 (Direct) | View |
| 2020-01-13 Purchase | 2020-01-21 5:47 pm | Apellis Pharmaceuticals Inc. | APLS | Morningside Venture Investments Ltd 10% Owner | 540,540 | $37 | $19,999,980 | 12,556,342 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-15 Gift | 2023-08-17 7:08 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 3,500,000 | $0 | 1,947,993 (Direct) | View |
| 2023-08-15 Gift | 2023-08-17 5:34 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 2,000,000 | $0 | 4,997,302 (Direct) | View |
| 2023-07-24 Other | 2023-07-25 4:01 pm | N/A N/A | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd 10% Owner | 16,919,155 | $0 | 16,919,155 (Direct) | View |
| 2022-10-18 Ownership | 2023-01-11 4:09 pm | N/A N/A | Kezar Life Sciences Inc. | KZR | Morningside Venture Investments Ltd 10% Owner | 120,000 | $0 | 5,931,740 (Direct) | View |
| 2022-09-12 Ownership | 2023-01-11 4:07 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 1,376,666 | $0 | 7,680,598 (Direct) | View |
Ownership | 2022-03-17 5:33 pm | N/A N/A | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 0 | $0 | 13,857,931 (Direct) | View |
| 2022-01-11 Conversion(A) | 2022-03-17 5:14 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 20,831,300 | $0 | 10,678,808 (Indirect) | View |
Ownership(A) | 2022-03-17 5:14 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 0 | $0 | 10,415,650 (Indirect) | View |
| 2022-02-02 Conversion(A) | 2022-03-17 5:11 pm | N/A N/A | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 1,000,000 | $10 | 13,857,931 (Direct) | View |
| 2022-02-02 Conversion(A) | 2022-03-17 5:11 pm | N/A N/A | GreenLight Biosciences Holdings PBC | GRNA | Morningside Venture Investments Ltd MVIL LLC 10% Owner | 12,857,931 | $0 | 13,857,931 (Direct) | View |
| 2022-02-02 Conversion | 2022-02-04 5:15 pm | N/A N/A | GreenLight Biosciences Holdings PBC | ENVI | Morningside Venture Investments Ltd 10% Owner | 1,000,000 | $10 | 13,858,188 (Direct) | View |
| 2022-02-02 Conversion | 2022-02-04 5:15 pm | N/A N/A | GreenLight Biosciences Holdings PBC | ENVI | Morningside Venture Investments Ltd 10% Owner | 12,858,188 | $0 | 13,858,188 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-25 4:46 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 20,831,300 | $0 | 10,678,808 (Direct) | View |
Ownership | 2022-01-25 4:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 0 | $0 | 10,415,650 (Direct) | View |